Dr. Christian Jung

Dr. Christian Jung


Successful investing is anticipating the anticipations of others.

— John Maynard Keynes


Christian joined Wellington Partners in 2016 as a Principal in the Life Sciences Team.

Christian obtained his MSc degree in Molecular Biotechnology from the Technical University of Munich and was awarded a PhD with distinction in Medical Science and Technology from the Technical University of Munich for his work on patient-specific induced pluripotent stem cells. The key articles generated in the context of his PhD were published in the New England Journal of Medicine, EMBO Molecular Medicine and FASEB Journal and have so far been cited more than 1000 times. In 2013, the thesis was recognized with the “Outstanding PhD thesis award” by the Luxembourg National Research Fund. During the course of his PhD, Christian was supporting the Life Science Team of Atlas Venture in Munich.

Prior to joining Wellington, Christian was a Senior Investment Manager with High-Tech Gründerfonds, the largest german seed investor with 886 Mio. € under management, where he completed and led the early-stage investments in coramaze technologies, WISEneuro, Amal Therapeutics, CuneSoft, PS Biotech, perora, Senostic, Rigontec and Dolosys. Christian was serving as a Board Director at coramaze technologies, as well as a Board Observer at Amal Therapeutics, WISEneuro and Rigontec (acquired by MSD).